Answers are grounded in this paper and cite their sources.
levels of DIM achievable by supplementation. In clinical trials these supplement doses have elicited few if any adverse effects. Sulforaphane from glucoraphanin can act synergistically with glucobrassicin-derived DIM and this may lead to opportunities for combinatorial approaches (supplement and food-based) in the clinic.
No takes yet. Share an insight, caveat, or question.
David E. Williams (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: